Understanding regenerative medicine inside war zones

Thanks to a $2.4 million grant from the DoD, Rion is collaborating with the Mayo Clinic and the U.S. Army Medical Research Institute to study the company’s Exosome Product for service members. Dr. Atta Behfar, Rion CEO and cofounder, explains.